D Budget Up Again

The information for these stories and the accompanying chart was gathered by freelance writers Bob Westgate and Susan Walton. WASHINGTON-Funding for science research, part of an overall federal budget that is expected to grow little in 1987, has increased significantly in several areas. Congress once again failed to approve appropriations bills for individual departments. Instead, on the day before it adjourned last month, it approved a $576 billion continuing resolution covering most government

Written byBob Westgate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The information for these stories and the accompanying chart was gathered by freelance writers Bob Westgate and Susan Walton.

WASHINGTON-Funding for science research, part of an overall federal budget that is expected to grow little in 1987, has increased significantly in several areas.

Congress once again failed to approve appropriations bills for individual departments. Instead, on the day before it adjourned last month, it approved a $576 billion continuing resolution covering most governmental operations. The 1,200 page document specifies how much money. each department can spend in the current fiscal year and contains specific requirements for thousands of programs. Even so, it gives most agencies considerable leeway in allocating money to particular activities, a task that will occupy administrators for the next several weeks.

One clear winner this year is the National Institutes of Health (see THE SCIENTIST, October, p. 1). The money to be spent on research grants of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies